The No Surprises Act's Independent Dispute Resolution (IDR) process has become one of the most consequential reimbursement tools available to out-of-network providers. Now, insurers are pushing to change it.

Major payors have argued that the IDR system is generating far more disputes than anticipated, producing inconsistent awards, and driving up healthcare costs. They are urging regulators to tighten eligibility, increase oversight, and place greater limits on arbitration.

Providers see the issue differently. They argue that IDR is working as Congress intended by giving providers a meaningful avenue to challenge inadequate reimbursement. From their perspective, higher arbitration awards often reflect underpayments rather than abuse of the system. Whether those arguments ultimately prevail remains to be seen. What is clear is that the legal landscape surrounding IDR continues to evolve through regulatory changes, litigation, and ongoing industry pressure.

For healthcare providers, the takeaway is practical rather than political. IDR remains a valuable reimbursement tool, but successful arbitration increasingly depends on careful documentation, persuasive evidence, and a strategy built around the statutory factors governing the process. Providers should also recognize that future reforms could alter when IDR is available, how disputes are evaluated, and what evidence carries the greatest weight. Organizations that understand these developments will be better positioned to protect reimbursement and respond to an increasingly aggressive payor environment.

At MDRXLAW, we counsel healthcare providers on reimbursement disputes, payor audits, and the evolving legal framework governing healthcare payments. You may contact our experienced healthcare litigation and arbitration attorneys at info@mdrxlaw.com or at 212.668.0200